A

Aquestive Therapeutics Inc
NASDAQ:AQST

Watchlist Manager
Aquestive Therapeutics Inc
NASDAQ:AQST
Watchlist
Price: 4.57 USD -5.38% Market Closed
Market Cap: 416.1m USD
Have any thoughts about
Aquestive Therapeutics Inc?
Write Note

Aquestive Therapeutics Inc
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aquestive Therapeutics Inc
Total Receivables Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
A
Aquestive Therapeutics Inc
NASDAQ:AQST
Total Receivables
$6m
CAGR 3-Years
-21%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Total Receivables
$16.2B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Total Receivables
$14.9B
CAGR 3-Years
8%
CAGR 5-Years
23%
CAGR 10-Years
17%
Pfizer Inc
NYSE:PFE
Total Receivables
$15.1B
CAGR 3-Years
8%
CAGR 5-Years
10%
CAGR 10-Years
4%
Merck & Co Inc
NYSE:MRK
Total Receivables
$12.2B
CAGR 3-Years
12%
CAGR 5-Years
8%
CAGR 10-Years
6%
Eli Lilly and Co
NYSE:LLY
Total Receivables
$12.1B
CAGR 3-Years
20%
CAGR 5-Years
17%
CAGR 10-Years
13%

See Also

What is Aquestive Therapeutics Inc's Total Receivables?
Total Receivables
6m USD

Based on the financial report for Jun 30, 2024, Aquestive Therapeutics Inc's Total Receivables amounts to 6m USD.

What is Aquestive Therapeutics Inc's Total Receivables growth rate?
Total Receivables CAGR 5Y
-10%

Over the last year, the Total Receivables growth was -41%. The average annual Total Receivables growth rates for Aquestive Therapeutics Inc have been -21% over the past three years , -10% over the past five years .

Back to Top